Mechanism of action, clinical effectiveness, and optimal therapeutic range

被引：360

作者：

Hirsh, J ^{[1
]}

Dalen, JE ^{[1
]}

Anderson, DR ^{[1
]}

Poller, L ^{[1
]}

Bussey, H ^{[1
]}

Ansell, J ^{[1
]}

Deykin, D ^{[1
]}

Brandt, JT ^{[1
]}

机构：

[1] Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada

来源：

CHEST | 1998年 / 114卷 / 05期

关键词：

D O I：

10.1378/chest.114.5_Supplement.445S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：445S / 469S

页数：25

共 250 条

[1]

Adcock DM, 1997, AM J CLIN PATHOL, V107, P105

[2]

AGENO W, 1998, J THROMB THROMBOLY S, V5, pS69

[3] ATRIAL-FIBRILLATION AND STROKE - 3 NEW STUDIES, 3 REMAINING QUESTIONS [J].

ALBERS, GW .

ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (13) :1443-1448

[4] STROKE PREVENTION IN NONVALVULAR ATRIAL-FIBRILLATION - A REVIEW OF PROSPECTIVE RANDOMIZED TRIALS [J].

ALBERS, GW ;

SHERMAN, DG ;

GRESS, DR ;

PAULSETH, JE ;

PETERSEN, P .

ANNALS OF NEUROLOGY, 1991, 30 (04) :511-518

[5]

ALTMAN R, 1991, J THORAC CARDIOV SUR, V101, P427

[6] HEREDITARY WARFARIN RESISTANCE - INVESTIGATION OF A RARE PHENOMENON [J].

ALVING, BM ;

STRICKLER, MP ;

KNIGHT, RD ;

BARR, CF ;

BERENBERG, JL ;

PECK, CC .

ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) :499-501

[7] EVALUATION OF A PORTABLE PROTHROMBIN TIME MONITOR FOR HOME-USE BY PATIENTS WHO REQUIRE LONG-TERM ORAL ANTICOAGULANT-THERAPY [J].

ANDERSON, DR ;

HARRISON, L ;

HIRSH, J .

ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (12) :1441-1447

[8]

Andrew Maureen, 1995, Blood, V86, p863A

[9]

[Anonymous], 1994, Lancet, V343, P499

[10]

[Anonymous], 1987, HEMATOL REV

← 1 2 3 4 5 6 7 8 9 10 →